Alice on for Tim Anderson's questions to Mineralys Therapeutics Inc (MLYS) leadership • Q1 2025
Question
An analyst from Bank of America asked about the status of early partnering discussions, what potential partners are waiting for, and how Mineralys could leverage a partnership to achieve peak sales potential through strategies like fixed-dose combinations or new indications.
Answer
Executive Jon Congleton declined to comment on specific partnering discussions but affirmed that partnerships are part of the strategy. He explained that a partner could help maximize value not only commercially but also through development partnerships in adjacent areas like heart failure or CKD, leveraging lorundrostat's potential as a leading aldosterone synthase inhibitor.